{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:28Z","timestamp":1761896488120,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.rdc.2016.12.010","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T19:33:24Z","timestamp":1489865604000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reproductive Health Screening in Women with Autoimmune Diseases"],"prefix":"10.1016","volume":"43","author":[{"given":"Latisha","family":"Heinlen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza F.","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2016.12.010_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/bjc.2015.439","article-title":"Gene-environment interaction and risk of breast cancer","volume":"114","author":"Rudolph","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rdc.2016.12.010_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000353138","article-title":"Breast cancer in systemic lupus erythematosus","volume":"85","author":"Cloutier","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.rdc.2016.12.010_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-center cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2016.12.010_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10549-015-3412-5","article-title":"Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population","volume":"151","author":"Khaliq","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.010_bib5","doi-asserted-by":"crossref","first-page":"e000156","DOI":"10.1136\/lupus-2016-000156","article-title":"Standardised incidence ratios (SIRs) for cancer after renal transplantation in systemic lupus erythematosus (SLE) and non-SLE recipients","volume":"3","author":"Ramsey-Goldman","year":"2016","journal-title":"Lupus Sci Med"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.010_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0961203316664595","article-title":"Breast cancer in systemic lupus","volume":"26","author":"Bernatsky","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.12.010_bib8","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A\u00a0meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.12.010_bib9","doi-asserted-by":"crossref","first-page":"453012","DOI":"10.1155\/2014\/453012","article-title":"Breast cancer risk in rheumatoid arthritis: an update meta-analysis","volume":"2014","author":"Tian","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.rdc.2016.12.010_bib10","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/annrheumdis-2014-205745","article-title":"TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study","volume":"74","author":"Raaschou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.12.010_bib11","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/art.39738","article-title":"Association between breast cancer recurrence and immunosuppression in rheumatoid arthritis and inflammatory bowel disease","volume":"68","author":"Mamtani","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.12.010_bib12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.1780400906","article-title":"Rheumatoid arthritis and the risk of malignancy","volume":"40","author":"Cibere","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.12.010_bib13","first-page":"1001","article-title":"Risk of cancer among rheumatoid arthritis patients in California","volume":"20","author":"Parekh-Patel","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.rdc.2016.12.010_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13075-014-0428-x","article-title":"Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study","volume":"16","author":"Chang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.12.010_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.1780240503","article-title":"Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy","volume":"24","author":"Nyberg","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.12.010_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/096120339400300112","article-title":"Systemic lupus erythematosus: predisposition for uterine cervical dysplasia","volume":"3","author":"Blumenfeld","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.2001.6207","article-title":"Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study","volume":"82","author":"Dhar","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rdc.2016.12.010_bib18","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection","volume":"50","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.12.010_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/rheumatology\/keq304","article-title":"Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia","volume":"50","author":"Liu","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.12.010_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00296-014-3157-1","article-title":"Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study","volume":"35","author":"Waisberg","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2016.12.010_bib22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/annrheumdis-2015-208263","article-title":"Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden","volume":"75","author":"Wadstrom","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.12.010_bib23","first-page":"785","article-title":"Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study","volume":"75","author":"Cordtz","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.12.010_bib24","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/art.39689","article-title":"Biologic disease-modifying antirheumatic drugs and risk of high-grade cervical dysplasia and cervical cancer in rheumatoid arthritis: a cohort study","volume":"68","author":"Kim","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2016.12.010_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/096120330000900711","article-title":"Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study","volume":"9","author":"Bateman","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib26","first-page":"751853","article-title":"Predisposition to cervical atypica in systemic lupus erythematosus: a clinical and cytopathological study","volume":"2015","author":"Al-Sherbeni","year":"2015","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.rdc.2016.12.010_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.090644","article-title":"Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study","volume":"37","author":"Tam","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.12.010_bib28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"Broad Spectrum HPV Vaccine Study. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2016.12.010_bib30","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.rdc.2016.12.010_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.12.010_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.12.010_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12 to 26 years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.rdc.2016.12.010_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203311429556","article-title":"Systemic lupus erythematosus following HPV immunization or infection?","volume":"21","author":"Soldevilla","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2177\/jsci.39.145","article-title":"A\u00a0case of systemic lupus erythematosus (SLE) following human papillomavirus (HPV) vaccination","volume":"39","author":"Ito","year":"2016","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.rdc.2016.12.010_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/djt032","article-title":"Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study","volume":"105","author":"Leval","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.rdc.2016.12.010_bib37","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/art.34542","article-title":"Cancer screening rates in patients with rheumatoid arthritis: no different from the general population","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2016.12.010_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0961203314552832","article-title":"Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic","volume":"24","author":"Quinzanos","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.12.010_bib39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.284.8.984","article-title":"Quality of care for patients with rheumatoid arthritis","volume":"28","author":"MacLean","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2016.12.010_bib40","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/ar3086","article-title":"The delivery of evidence-based preventive care for older Americans with arthritis","volume":"12","author":"Curtis","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.12.010_bib41","first-page":"1940","article-title":"Preventive medical services among patients with rheumatoid arthritis","volume":"30","author":"Kremers","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.12.010_bib42","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar3011","article-title":"Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study","volume":"12","author":"Yazdany","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2016.12.010_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2013.04.003","article-title":"Primary preventive services in patients with systemic lupus erythematosus: Study from a population-based sample in southeast US","volume":"43","author":"Drenkard","year":"2013","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:15:41Z","timestamp":1760181341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889857X16301132"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive Health Screening in Women with Autoimmune Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}